Neurogene (NGNE)
NASDAQ:NGNE
US Market
Holding NGNE?
Track your performance easily

Neurogene (NGNE) Cash flow

438 Followers

Neurogene Cash Flow

NGNE's free cash flow for Q2 2024 was $-16.26M. For the 2024 fiscal year, NGNE's free cash flow was decreased by $-5.00M and operating cash flow was $-15.80M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -71.82M$ -51.42M$ -45.61M$ -47.56M$ -24.57M$ -15.39M
Investing Cash Flow
$ 21.66M$ 25.64M$ -59.13M$ -3.26M$ -2.22M$ -688.00K
Financing Cash Flow
$ 86.72M$ 92.48M$ 161.00K$ 732.00K$ 77.14M$ 82.24M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 436.30M$ 148.72M$ 38.77M$ 143.34M$ 193.43M$ 143.09M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 19.00K$ 12.00K---$ 1.00K
Issuance Of Capital Stock
$ 92.34M$ 92.34M--$ 71.67M$ 81.04M
Issuance Of Debt
$ 308.00K$ -29.00K$ -55.00K$ -51.00K--
Repayment Of Debt
$ 308.00K$ -29.00K$ -55.00K$ -51.00K$ -49.00K$ -9.00K
Free Cash Flow
$ -74.23M$ -51.72M$ -46.72M$ -50.82M$ -26.79M$ -16.27M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Neurogene Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis